Company news
Proteomics International Laboratories Ltd. news in 2018
Proteomics International Laboratories Ltd.'s news releases, calls and decks from 2018, newest first.
Proteomics signs PromarkerD agreement with US big pharma
November 25, 2018
PromarkerD kit version complete- commercial release imminent
November 8, 2018
Appendix 4C - September 2018 Quarterly Report
October 29, 2018
Diabetic kidney disease test enters Europe & Export Award
October 23, 2018
Proteomics receives $834k in R&D Tax Incentive
October 16, 2018
Proteomics & Atturos partner to target diagnostics in Europe
September 19, 2018
Proteomics to receive $928k from sale of shareholding in CPR
September 12, 2018
Diagnostics update- Pipeline yields potential new biomarkers
August 22, 2018
Appendix 4C - June 2018 Quarterly Report
July 29, 2018
Proteomics secures major contract - nears cash flow positive
July 18, 2018
Further information on new licence deals in USA and Mexico
June 20, 2018
Proteomics signs deal with Patia for PromarkerD in Mexico
June 17, 2018
Proteomics signs deal to launch PromarkerD test in US market
May 28, 2018
Appendix 4C - March 2018 Quarterly Report
April 25, 2018
Europe PromarkerD patent granted for diabetic kidney disease
April 18, 2018
Underwriters take final $342,000 of Proteomics Options
April 16, 2018
Conversion of 90% of Proteomics Options raises of $3m
April 5, 2018
Directors Exercise PIQ Options
March 23, 2018
Proteomics secures underwriting - PIQ Options to raise $3.4m
March 13, 2018
Proteomics launches PromarkerD
March 6, 2018
Strategic alliance and investment in CPR Pharma Services
February 1, 2018
PromarkerD diabetic kidney disease patent granted in Japan
January 28, 2018
Appendix 4C - December 2017 Quarterly Report
January 25, 2018
Decks in 2018
- Shareholder Meeting (November 2018)
Shareholder meeting · 27 slides · Nov 22, 2018
- Investor Presentation (February 2018)
Investor deck · 22 slides · Feb 8, 2018